It promotes survival of MM cells by activating the nuclear factor kappa B (NF-κB) signaling pathway and by stimulating autocrine IL-6 production, and induces MM cell migration via upregulation of monocyte chemoattractant protein (MCP)-1 in tumor cells [68]. The gene discussed is NFKB1; the disease is Miyoshi myopathy.